Botox Cosmetic: FDA Approved for Forehead, Crow’s Feet and Glabellar Wrinkles.

Botox Cosmetic: FDA Approved for Forehead, Crow’s Feet and Glabellar Wrinkles.

On October 3, 2017, Allergan announced the FDA approval of BOTOX® Cosmetic for its third indication, the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity in adults. This approval makes BOTOX® Cosmetic the first and only neurotoxin indicated for three facial treatment areas:

  • Forehead lines
  • Crow’s feet lines
  • Glabellar lines (lines between the eyebrows)

As the category leader, BOTOX® Cosmetic is the only neurotoxin brand to receive approval of aesthetic indications beyond glabellar lines in the U.S.

“Allergan recognizes that forehead lines are a top area of concern for patients,” says David Nicholson, Chief Research and Development Officer at Allergan. “Our goal in pursuing a third indication for BOTOX® Cosmetic for the temporary improvement in the appearance of moderate to severe forehead lines was based on our desire to study the patient selection, dosing and injection pattern to help provide optimal treatment outcomes.”

The BOTOX® Cosmetic story began in 2002 when the brand helped establish the aesthetic market with its first FDA approval to temporarily improve the appearance of moderate to severe frown lines between the eyebrows (glabellar lines). The momentum continued in 2013 when BOTOX® Cosmetic was approved for the temporary improvement in the appearance of moderate to severe crow’s feet lines. The addition of this third indication furthers Allergan’s mission to continue providing patients and physicians with products designed to address specific patient needs.

In clinical trials, BOTOX® Cosmetic continually demonstrated efficacy compared with placebo in the reduction of the severity of forehead lines, as assessed by both the investigator and the subject.

Approved for use in over 75 countries, BOTOX® Cosmetic is the most widely researched and studied treatment of its kind. The safety and efficacy have been evaluated in Allergan clinical studies and described in nearly 500 peer-reviewed articles in scientific and medical journals. BOTOX® Cosmetic is manufactured in a state-of-the art facility under strict quality and safety standards.

Dr. DeConti has performed over 10,000 injections since BOTOX® Cosmetic was introduced in 2002. As a highly credentialed surgeon with the American Board of Plastic Surgery and training in Craniofacial Surgery, he is an expert in the intimate details of facial muscle anatomy. This knowledge allows Dr. DeConti to perform BOTOX® Cosmetic injections accurately and effectively for the finest and most optimum results with the least amount of risk.

To learn how BOTOX® Cosmetic can help you look younger, call 804 673-8000 and schedule a facial rejuvenation consultation at DeConti Plastic Surgery today.  Dr. DeConti participates in the Allergan Brilliant Distinctions Loyalty Program to help benefit your aesthetic needs.

CareCredit Richmond Virginia DeConti Plastic Surgery
Top